Key result
Functional incomplete revascularisation (Q-rFSS ≥1) was associated with a significantly higher risk of MACE at 2 years compared to functional complete revascularisation (HR 3.21).
Why the study?
This study aimed to investigate the prognostic ability of quantitative flow ratio-guided residual functional SYNTAX score (Q-rFSS) and functional incomplete revascularisation in STEMI patients undergoing PCI.
Does functional incomplete revascularisation (assessed by Q-rFSS >= 1) increase the risk of MACE compared to functional complete revascularisation in STEMI patients undergoing PCI?
Cohort (n=354)
Blinded outcome assessors
No
Does functional incomplete revascularisation (assessed by Q-rFSS >= 1) increase the risk of MACE compared to functional complete revascularisation in STEMI patients undergoing PCI?
Effect estimate: HR 3.21 (95% CI 1.74 to 5.91)
Absolute Event Rate: 22% vs 7.4%
p-value: p=<0.001
In STEMI patients undergoing PCI, functional incomplete revascularization assessed by QFR-guided residual functional SYNTAX score is associated with a significantly higher risk of long-term MACE, improving risk stratification over anatomic assessment alone.
BACKGROUND: Functional incomplete revascularisation (IR) is associated with a higher risk of major adverse cardiac events (MACE) during long-term follow-up in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI). AIMS: This study aimed to investigate the prognostic ability of quantitative flow ratio (QFR)-guided residual functional SYNTAX score (Q-rFSS) and functional IR in STEMI patients undergoing PCI. METHODS: In total, 354 consecutive STEMI patients who successfully underwent PCI were included. Q-rFSS was defined as residual SYNTAX score (rSS) measured only in vessels with QFR ≤0.8. The primary outcome was MACE (a composite of all-cause mortality, myocardial infarction, and ischaemia-driven revascularisation) at 2 years. RESULTS: At two-year follow-up, functional IR (Q-rFSS ≥1) showed significantly higher risk for MACE than functional complete revascularisation (CR) (Q-rFSS=0) (functional IR vs CR, 22.0% vs 7.4%; hazard ratio [HR] 3.21; 95% confidence interval [Cl]: 1.74 to 5.91; p<0.001). The area under the curve (AUC) of Q-rFSS (0.738, 95% CI: 0.659 to 0.817) was significantly greater than that of rSS (0.648, 95% CI: 0.547 to 0.749). The C-statistic for MACE also increased after the addition of Q-rFSS to the clinical risk factors. Q-rFSS significantly improved risk classification compared with rSS (net reclassification improvement 0.439, 95% CI: 0.201 to 0.548; p<0.001). CONCLUSIONS: Functional IR is associated with higher risk of MACE during long-term follow-up in STEMI patients undergoing PCI. Q-rFSS has a better prognostic ability for the risk of MACE.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2021) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=354). Functional incomplete revascularisation (Q-rFSS ≥1) vs. Functional complete revascularisation (Q-rFSS = 0) was evaluated on Major adverse cardiac events (MACE) at 2 years (HR 3.21, 95% CI 1.74 to 5.91, p=<0.001). Functional incomplete revascularisation (Q-rFSS ≥1) was associated with a significantly higher risk of MACE at 2 years compared to functional complete revascularisation (HR 3.21).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: